Hepatoprotective effect of propagermanium on Corynebacterium parvum and lipopolysaccharide-induced liver injury in mice

Scandinavian Journal of Immunology

Volumn 48, Issue 2, 1998, Pages 183-191

  Yokochi, S ^a   Ishiwata, Y ^a   Hashimoto, H ^a   Ninomiya, F ^a   Suzuki, T ^a  

^a SANWA KAGAKU KENKYUSHO CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYETHYLGERMANIUM SESQUIOXIDE; LIPOPOLYSACCHARIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DNA CONTENT; DRUG EFFECT; ENZYME ACTIVITY; HEPATITIS; LIVER INJURY; LIVER PROTECTION; MEDIATOR RELEASE; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ALANINE TRANSAMINASE; ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, CD11; ASPARTATE AMINOTRANSFERASES; CD4-POSITIVE T-LYMPHOCYTES; CORYNEBACTERIUM INFECTIONS; FEMALE; INTERFERON TYPE II; INTERLEUKIN-12; LIPOPOLYSACCHARIDES; LIVER; LIVER DISEASES; LYMPHOCYTE SUBSETS; MICE; MICE, INBRED ICR; MONOCYTES; ORGANOMETALLIC COMPOUNDS; PROPIONIBACTERIUM ACNES;

EID: 0031813950     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1998.00356.x     Document Type: Article

References (45)

1. Hirayama C, Fujisawa K, Suzuki H et al. Multicenter randomized controlled clinical trial of proxigermanium in chronic active hepatitis. VIIth Biennial Scientific Meeting of the Asian Pacific Association for the Study of the Liver. Jakarta. Indonesia: Asian Pacific Association for the Study of the Liver 1990:102.
2. Hirayama T, Fujisawa K, Suzuki H et al. Clinical evaluation of proxigermanium in patients with chronic hepatitis B and non B hepatitis-double blind test. Igaku No Ayumi 1990;154:663-80.
3. Ishiwata Y, Yokochi S, Suzuki E et al. Effects of proxigermanium on interferon production and 2′,5′-oligoadenylate synthetase activity in the lung of influenza virus-infected mice and in virus-infected human peripheral blood mononuclear cell cultures. Arzneim-Forsch/Drug Res 1990;40:896-9.
4. Ishiwata Y, Suzuki E, Yokochi S et al. Studies on the antiviral activity of propagermanium with immnostimulating action. Arzneim-Forsch/Drug Res 1994;44:357-61.
5. Ishiwata Y, Suzuki E, Otsuka T et al. Stimulation of cellular immune function by propagermanium. Oyo Yakuri/Pharmacometrics 1994;47:155-64.
6. Ferluga J, Allison AC. Role of mononuclear infiltrating cells in pathogenesis of hepatitis. Lancet 1978;II:610-11.
7. Arthur MJP, Saunders PK, Wright R. Oxygen derived free radicals promote hepatic injury in the rat. Gastroenterology 1985;89:1114-22.
8. Arthur MJP, Bentley IS, Tanner AR, Kowalski Saunders P, Millwaed-Sadler GH, Wright R. Corynebacterium parvum-elicited hepatic macrophage demonstrate enhanced respiratory burst activity compared with resident Kupffer cells in the rat. Gastroenterology 1986;91:174-81.
9. Mochida S, Ogata I, Ohta Y, Yamada S, Fujiwara K. In situ evaluation of the stimulatory state of hepatic macrophages based on their ability to produce superoxide anions in rats. J Pathol 1989;158:67-71.
10. Arai M, Mochida S, Ohno A, Ogata I, Fujiwara K. Sinusoidal endothelial cell damage by activated hepatic macrophages in rat liver necrosis. Gastroenterology 1993;104:1466-71.
11. Tanaka Y, Kobayashi K, Takahashi A et al. Inhibition of inflammatory liver injury by a monoclonal antibody against lymphocyte function-associated antigen-1. J Immunol 1993;151:5088-95.
12. Tanaka Y, Takahashi A, Kobayashi K et al. Establishment of a T cell-dependent nude mouse liver injury model induced by Propionibacterium acnes and LPS. J Immunol Methods 1995;182:21-8.
13. Tanaka Y, Takahashi A, Watanabe K et al. A pivotal role of IL-12 in Th1-dependent mouse liver injury. Int Immunol 1995;8:569-76.
14. 2 analog in treatment of massive hepatic necrosis associated with endothelial cell injury and diffuse sinusoidal fibrin deposition. Digest Dis Sci 1995;40:41-7.
15. Smith SR, Terminelli C, Denhardt G, Narula S, Thorbecke GJ. Administration of interleukin-10 at the time of printing protects Corynebacterium parvum-primed mice against LPS- and TNF-α-induced lethality. Cell Immunol 1996;173:207-14.
16. Harbrecht BG, Silvio MD, Demetris AJ, Simmons RL, Billiar TR. Tumor necrosis factor-α regulates in vivo nitric oxide synthesis and induces liver injury during endotoxemia. Hepatology 1994;20:1055-60.
17. Ikeda N, Mukaida N, Kaneko S et al. Prevention of endotoxin-induced acute lethality in Propionibacterium acnes-primed rabbits by an antibody to leukocyte integrin β2 with concomitant reduction of cytokine production. Infect Immun 1995;63:4812-17.
18. Okamura H, Kawaguchi K, Shoji K, Kawade Y. High level induction of γ interferon with various mitogens in mice pretreated with Propionibacterium acnes. Infect Immun 1982;38:440-3.
19. Kobayashi M, Fitz L, Ryan M et al. Identification and purification of natural killar cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med 1989;170: 827-45.
20. Okamura H, Tsutsui H, Komatsu T et al. Cloning of a few cytokine that induces IFN-γ production by T cells. Nature 1995;378:88-91.
21. Yamada S, Ogata I, Hirata K, Mochida S, Tomiya T, Fujiwara K. Intravascular coagulation in development of massive hepatic necrosis induced by Corynebacterium parvum and endotoxin in rats. Scand J Gastroenterol 1989;24:293-8.
22. Mohler KM, Torrance DS, Smith CA et al. Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists. J Immunol 1993;151:1548-61.
23. Suitters AJ, Foulkes R, Opal SM et al. Differential effect of isotype on efficacy of anti-tumor necrosis factor a chimeric antibodies in experimental septic shock. J Exp Med 1994;179:849.
24. Fujioka N, Mukaida N, Hanada A et al. Preparation of specific antibodies against murine IL-lra and the establishment of IL-lra as endogenous regulator of bacteria-induced fulminant hepatitis in mice. J Leukoc Biol 1995;58:90-8.
25. Tsutsui H, Mizoguchi Y, Morisawa S. Importance of direct hepatocytolysis by liver macrophages in experimental fulminant hepatitis. Hepato-Gastroenterol 1992;39:553-9.
26. Tripp CS, Kanagawa O, Unanue ER. Secondary response to Listeria infection requires IFN-γ but is partially independent of IL-12. J Immunol 1995;155:3427-32.
27. Miller MA, Skeen MJ, Ziegler HK. Protective immunity to Listeria monocytogenes elicited by immunization with heat-killed Listeria and IL-12. Ann NY Acad Sci 1996;797:207-27.
28. Song F, Matsuzaki G, Mitsuyama M, Nomoto K. Differential effects of viable and killed bacteria on IL-12 expression of macrophages. J Immunol 1996;156:2979-84.
29. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR. An essential role for interferon-γ in resistance to Mycobacterium tuberculosis infection. J Exp Med 1993;178:2249-54.
30. Scott P, Narowitz P, Coffman RL, Pearce E, Sher A. Immunoregulation of exacerbation belong to different Th subsets and respond to distinct parasite antigens. J Exp Med 1988;168:1675-84.
31. + T cells but induces type 1 T cells in the liver by induction of IL-12 and IL-18 production from Kupffer cells. J Immunol 1997;159:97-106.
32. Okura A, Nakadaira M, Naito K, Ishizuka A, Nakadaira M, Umezawa H. Effect of forphenicinol on γ-interferon production in mice sensitized with BCG. J Antibiotics 1986;39:569-74.
33. Nagakawa J, Hishinuma I, Hirota K et al. Involvement of tumor necrosis factor-α in the pathogenesis of activated macrophage-mediated hepatitis in mice. Gastroenterology 1990;99:758-65.
34. Nagakawa J, Hishinuma I, Miyamoto K et al. Protective effects of (2E)-3-[5-(2,3-dimethoxy-6-methyl-1, 4-benzoquinoyl)]-2-nonyl-2-propenoic acid on endotoxin-mediated hepatitis in mice. J Pharmacol Exp Therapeutics 1992;262:145-50.
35. Yoshitake I, Ohishi E, Kubo K. Hepatoprotective effects of 1-[(2-thiazolin-2-yl)-amino]acetyl-4-(1,3-dithiol-2-ylidene)-2,3,4,5-tetrahydro- 1H-1-benzazepin-3,5-sione hydrochloride (KF-14363) in various experimental liver injuries. Jpn J Pharmacol 1991;57:127-36.
36. Tanaka Y, Takahashi A, Kobayashi K et al. Hepatoprotective effect of SY-640, a novel acetamide derivative, on Propionibacterium acnes and lipopolysaccharide-induced liver injury in mice. Arch Int Pharmacodyn 1995;329:319-30.
37. Mochida S, Ohno A, Arai M, Tamatani T, Miyasaka M, Fujiwara K. Role of adhesion molecules in the development of massive hepatic necrosis in rats. Hepatology 1996;23:320-8.
38. Nakayama M, Arai K, Hasegawa K et al. Adhesion molecules on intermediate TCR cells. II. Hepatoprotective effects of hyaluronic acid on acute liver injury. Cell Immunol 1995;166:275-85.
39. Arai T, Hiromatsu K, Kobayashi N et al. IL-10 is involved in the protective effect of dibutyryl cyclic adenosine monophosphate on endotoxin-induced inflammatory liver injury. J Immunol 1995;155:5743-9.
40. Nagai H, Aoki M, Shimazawa T, Yakuo I, Koda A, Kasahara M. Effect of OKY-046 and ONO-3708 on liver injury in mice. Jpn J Pharmacol 1989;51:191-7.
41. Chiao H, Foster S, Thomas R, Lipton J, Star RA. α-Melanocyte-stimulating hormone reduces endotoxin-induced liver. J Clin Invest 1996;97:2038-44.
42. Harbrecht BG, Stadler J, Demetris AJ, Simmons RL, Billiar TR. Nitric oxide and prostaglandins interact to prevent hepatic damage during murine endotoxemia. Am J Physiol 1994;266:G1004-G1010.
43. Uchida K, Sakaida I, Kimura T et al. Evaluation of the effect of FK506 in rat acute hepatic insufficiency model. Acta Hepatologica Japonica 1996;37(Suppl. 3):113.
44. Ando K, Moriyama T, Guidotti LG et al. Mechanisms of class I restricted immunopathology, a transgenic mouse of fulminant hepatitis. J Exp Med 1993;178:1541-54.
45. Chisari FV. Hepatitis B virus transgenic mice: Insights into the virus and the disease. Hepatology 1995;22:1396-25.